The purpose of this study was to explore the characteristics of blood glucose spectrum, changes of endocrine/exocrine pancreatic function and the correlation between them in patients with PPDM-C.
The benefits of this study to participants include: 1. It will help to make early diagnosis or risk screening for the potential related risks and concomitant diseases of the disease; 2. Provide necessary suggestions for the treatment and intervention of the disease, or provide useful information for the related research of the disease. 3. We will provide Abbott version h dynamic glucose meter and assessment of internal and external secretion function. The researcher will provide professional endocrine related lifestyle and drug guidance for the subjects according to their CGMS data. The risks that this study may bring to participants are: There may be some very small risks in specimen collection, including transient pain, local cyanosis, etc. a few people will have mild dizziness or extremely rare needle infection.
Study Type
OBSERVATIONAL
Enrollment
2,000
Blood glucose profile characteristics of patients with PPDM-C
Time frame: From February 2025 to December 2025
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.